This site is intended for Healthcare professionals only.
×

Clinical trial: Melatonin offers hope for ADHD bedtime shut-eye

Clinical trial: Melatonin offers hope for ADHD bedtime shut-eye

Sleep is vital to wellbeing, but children with attention deficit hyperactivity disorder ADHD often have trouble drifting off.

University of Queensland researchers are recruiting trial participants for a study investigating the effectiveness of the natural hormone melatonin on children with ADHD who are struggling to settle at bedtime.

UQ School of Medicine’s Dr Jane Nikles said stimulant medication used to help ADHD symptoms could make sleep problems worse. “Children with ADHD often have difficulty settling down in the evening and this can be further complicated by the medications used to treat ADHD, including stimulants marketed as Ritalin and Dexamphetamine,” Dr Nikles said.

0 comment(s) on Clinical trial: Melatonin offers hope for ADHD bedtime shut-eye

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
    Source: MNT

    Opinion Polls

    Should Government Doctors be allowed to do Private Practice?